Related Experiment Video

Updated: Jul 18, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa

Dianren Xia1, Harish Srinivas, Young-Ho Ahn

  • 1Department of Thoracic/Head and Neck Medical Oncology, University of Texas M D Anderson Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.

The Journal of Biological Chemistry
|December 13, 2006
PubMed

Insights

Mitogen-activated protein kinase kinase-4 (MKK4) promotes non-small cell lung cancer cell survival by inhibiting PTEN expression via NFkappaB activation. This pathway involves MKK4 activating NFkappaB, which suppresses PTEN, ultimately supporting cancer cell survival.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Mitogen-activated protein kinase kinase-4 (MKK4/SEK1) is known to cooperate with phosphatidylinositol 3-kinase in maintaining non-small cell lung cancer (NSCLC) cell survival.
  • The precise biochemical mechanisms underlying this prosurvival role of MKK4 in NSCLC remain incompletely understood.

Purpose of the Study:

  • To elucidate the downstream signaling pathways regulated by MKK4 that contribute to cell survival in NSCLC.
  • To identify the specific molecular interactions and transcriptional events mediated by MKK4.

Main Methods:

  • Genetic manipulation of MKK4 expression in mouse embryo fibroblasts (MEF) and NSCLC cell lines.
  • Assessment of apoptosis susceptibility under various stress conditions (LY294002, paclitaxel, serum starvation).
  • Analysis of PTEN expression, NFkappaB activation (including RelA/p65 nuclear translocation and NFkappaB2 processing), and PTEN transcription.

Main Results:

  • MKK4-null MEF cells exhibited increased susceptibility to apoptosis compared to wild-type cells.
  • MKK4 was found to promote MEF cell survival by downregulating PTEN expression.
  • MKK4 activates NFkappaB, a transcriptional repressor of PTEN, and is essential for RelA/p65 nuclear translocation and NFkappaB2 processing.
  • A subset of NSCLC cell lines characterized by high MKK4, high NFkappaB, and low PTEN expression demonstrated resistance to apoptosis.

Conclusions:

  • MKK4 promotes cell survival in NSCLC by activating phosphatidylinositol 3-kinase signaling.
  • This prosurvival effect is mediated through an NFkappaB-dependent inhibition of PTEN transcription.
  • The MKK4/NFkappaB/PTEN axis represents a key pathway for maintaining NSCLC cell viability.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...